Big Market Research recently added a report titled “Protein Therapeutics Market by Product and Application- Global Opportunity Analysis and Industry Forecast, 2017-2023”. As per the findings of the report, the global protein therapeutics market, valued at $140,109 million in 2016, is projected to garner $217,591 million by 2023. The industry is anticipated to grow at a CAGR of 6.5% during the forecast period, 2017-2023. The report divulges information about the rigorous research methodologies adopted to acquire data. The data presented in the report is the result of extensive primary and secondary research of the market carried out by research analysts and with crucial inputs from core industry experts.
Protein therapy involves the timely delivery of specific amounts of vital proteins to the human body that ensures optimal functioning of the glands and vital organs of an individual’s body. The primary principle is like that of gene therapy. Several diseases such as hepatitis, diabetes, lymphoma, and other conditions can be treated effectively by adopting protein therapeutics.
The robust growth of the global protein therapeutics market can be attributed to several factors. The report provides information about the top market dynamic aspects and the factors that contribute to the growth or the failure of the market. The surge in healthcare expenditure and the rise in the incidence of chronic diseases fuel the need for protein therapy. An increase in the investments made by leading market players in the research and development of the sector, along with the growth in proteomics research, drive the growth of the market. However, the high treatment costs and the stringent regulations imposed by the government on the use of protein therapeutics, restrict the growth of the global industry.
The report analyzes the presence of the market categorized based on the product, application, and the geography. By product, the market is classified as monoclonal antibodies, erythropoietin, insulin, human growth hormone, interferon, fusion protein, and follicle stimulating hormone. The applications include immunologic disorders, cancer, metabolic disorders, hematological disorders, genetic disorders, hormonal disorders, and others. The presence of the market is analyzed in the regions of North America, Europe, LAMEA, and Asia-Pacific.
The leading players in the global protein therapeutics market include Johnson & Johnson, Amgen Inc., Eli Lilly and Company, Abbott Laboratories, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Baxter International Inc., Merck & Co., Inc., Pfizer Inc., and Sanofi among others. The report includes important information of the profiled organization, such as the company overview, snapshot, product portfolio, operating business segments, business performance, and the key strategic moves adopted by these players to gain a strong foothold in the market.
Key Benefits of the Report: